Best of SABCS® - West

Regional Director
Hope S. Rugo, MD, FASCO
Professor of Medicine Director, Breast Oncology and Clinical Trials Education UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, CA
Program Goals & Content Overview
As new clinical data continues to emerge as a result of ongoing research in breast cancer diagnostics and therapeutics, official Best of SABCS® programs cover these important developments in each of the live, regional events. Each regional event provides an educational forum for local researchers and clinicians to discuss the most pertinent basic, translational, and clinical breast cancer research presented at the annual SABCS® meeting.
Topics and discussions for each Best of SABCS® program are drawn from key presentations at SABCS® 2023, focusing on results of breast cancer research that helps clinicians understand current trends and forthcoming treatments that will optimize patient care outcomes. Significantly important content from SABCS® includes new drug therapy approvals and clinical trial results, updates in breast cancer screening and diagnostics, and best practices to be implemented in clinical care of patients.
The goals of the Best of SABCS® programs are to review and critically assess practice-changing results of emerging breast cancer research, propose best practices for implementing diagnostic and therapeutic strategies, and close knowledge and clinical practice gaps in the management of patients with breast cancer.
Date & Time
January 27, 2024 8:30 am - 1:30 pm
The Claremont Hotel, 41 Tunnel Road, Berkeley, CA - 94705
Program Fee
Nurse/Nurse Practitioner/Physician Assistant
ANCO Professional Member

We are pleased to be partnering with the Association of Northern California Oncologists for this symposium.

A special discounted registration rate of $35 is offered to ANCO members.

A small block of rooms is available at a discounted rate. To book your stay, please go to this link:

Welcome to Best of SABCS-West 2024
2023 Preliminary Agenda
7:30 - 8:30 AM

Registration Open, Continental Breakfast-Claremont Ballroom

8:30 - 8:40 AM
Welcome and Program Overview, Pre-Test Questions

Meeting- Empire Ballroom. S. Rugo, MD, Professor of Medicine and Winterhof Professor of Breast Oncology; Director, Breast Oncology and Clinical Trials Education, University of California San Francisco, Helen Diller Family Comprehensive Cancer Centerasas

8:40 - 9:10 AM
Updates in Translational Research and Biomarkers

Mark Pegram, MD - Yuan-Huey Hung Endowed Professor of Medical Oncology, Stanford University

9:10 - 9:40 AM
New Developments in the Treatment of Early Stage HR+ Breast Cancer

Laura Huppert, MD - Assistant Professor of Medicine, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center

9:40 - 10:10 AM
Insights in Survivorship and Health Disparities

Fauzia Riaz, MD - Clinical Assistant Professor of Medicine-Oncology Stanford University School of Medicine

10:10 - 10:30 AM
Panel Discussion and Audience Q and A

10:30 - 10:45 AM
Refreshment Break and Visit with Exhibitors

10:45 -11:15 AM
Advances in Approaches to Local-regional Disease

Michael D. Alvarado, MD – Professor of Clinical Surgery, Director of Breast Surgery Oncology Fellowship, University of California San Francisco

11:15 -11:45 AM
Advances in Novel Therapeutics for HR+/HER2- Advanced Breast Cancer

Mili Arora, MD, Associate Professor of Medicine The Joe Sullivan Hematology/Oncology Fellowship Program Director Division of Hematology/Oncology, UC Davis Comprehensive Cancer Center

11:45 -12:30 PM
Expanded Horizons: A Treatment for HR+/HER2- mBC and mTNBC

Product Theatre with Lunch- Skyline Ballroom - Nitin Rohatgi, MD, MBA, Medical Director, Breast Cancer Program, Chair, Section of Hematology/Oncology, Sutter Medical Center

12:30 -1:00 PM
Updates in the Treatment of TN and HER2+ Breast Cancer

Helen Chew, MD, Professor of Medicine, UC Davis Comprehensive Cancer Center

1:00 - 1:20 PM
Panel Q and A

1:20 -1:30 PM
Closing Remarks, Evaluations and Post-Test Questions

1:20 PM

Accreditation Statement

The UT Health Science Center San Antonio is accredited by the ACCME (Accreditation Council for Continuing Medical Education) to provide continuing medical education for physicians.

The UT Health Science Center San Antonio has approved this program for AMA PRA Category 1 Credits™.

Target Audience
These regional Best of SABCS programs are directed to academic and community physicians, medical residents and fellows training in oncology subspecialties, physician assistants, nurse practitioners and basic/translational researchers involved in breast cancer. Specialties include medical, surgical, gynecologic, and radiation oncology, as well as other pertinent healthcare professionals involved in breast cancer medicine.
These programs are supported by educational grants from
Astra Zeneca
Daiichi Sankyo
Puma Biotechnology